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ESBD and received AE.
Materials and Methods: The patients with irreversible ESBD and had
received AE in Hualien Tzu Chi General Hospital were retrospectively
reviewed. Vediourodynamic studies had been investigated in all patients
before the AE and at the follow-up. The patients were classiﬁed according
to the etiologies of ESBD including neurogenic voiding dysfunction (NVD,
such as spinal cord injury (SCI) and meningomyelocele) and inﬂammatory
bladder disease (IBD, such as interstitial cystitis, ketamine cystitis, tuber-
culosis cystitis and eosinophilic cystitis), post pelvic cancer surgery and the
others etiologies. The complications of the operation, active lower urinary
tract problems and patients self reported satisfaction grading with a 4
point scale (0: not satisﬁed, 1: mild satisﬁed, 2: moderate satisﬁed, 3:
excellent satisﬁed) at follow-up were recorded. The episodes of urinary
tract infection (UTI) were also recorded.
Results: A total 102 patients with mean age of 39.4± 18.7 years old had
been investigated at amean 78months follow-up. The cystometric bladder
capacity (CBC), compliance, self-voided volume and post-void residual
urine in overall patients had signiﬁcantly increased from before operation
to the follow-up. At follow-up, ﬁfty-six patients had spontaneous voiding
without any urethral catheterization, fourty-three patients had to perform
clean intermittent catheterization (CIC), and 3 patients choose to keep an
indwelling urethral catheter. Twenty-nine patients presented with ves-
icoureteral reﬂux at baseline, 23 patients had received ureter reimplanta-
tion, and only 2 patients still had VUR at follow-up. All the patients with
NVD (n¼ 45), IBD (n¼ 35), post pelvic cancer surgery (n¼ 15) and the
others etiology (n¼ 7) could signiﬁcantly improve CBC and compliance at
follow up. CIC had to be performed in 33 (73.3%) patients with NVD, six
patients (40%) with post pelvic cancer surgery, four (57.1%) patients with
the others etiologies and only 2patients (6%)with IBD (p< 0.001). Fifty-four
(52.7%) patients hadmoderate to excellent satisfaction, and the satisfaction
rate between different groups did not have signiﬁcant difference
(p¼ 0.362). The most common reason of dissatisfaction was CIC (41.7%),
following by urinary incontinence (25.0%) and recurrent UTI (16.7%). Most
patients (65.6%) had UTI episodes frequency less than 1 times per year, 30%
patients had 1 to3 timesUTI per year and4.3 %patients hadUTImore than 3
times per year. The UTI frequency between different etiologies is not sig-
niﬁcant, but the patientswhohad toCIC or indwelling urethral catheterhad
a higher rate or recurrent UTI. (p¼ 0.039) Bladder stones were found in 5
patients and two patients with IBD developed entero-vesical anastomosis
stricture at follow-up.
AE could signiﬁcantly improve bladder capacity and compliance in the
ESBD patients with different etiologies in a long-term follow-up. The
satisfaction and complication rate also did not have difference between the
patients with different etiologies. CIC had to be performed inmost patients
with NVD and this is the major reason of dissatisfaction. Recurrent UTI is a
common complication and the patients had to perform CIC or indwelling
urethral catheter should beware of recurrent UTI.
Conclusion: AE for the patients with ESBD is a safe and effective procedure
to improve bladder capacity and compliance. The most common compli-
cation is UTI, and the patients should to receive long-term regular follow-
up in urology clinic.
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PD12-4:
THE IMPACT OF DIABETES MELLITUS ON PATIENTS RECEIVING ROBOTIC
ASSISTED RADICAL PROSTATECTOMY FOR PROSTATE CANCER
Chen-Pang Hou, Pai-Yen Pan, Phei-Lang Chang, Chien-Lun Chen,
Yu-Hsiang Lin, Pei-Shan Yang, Ke-Hung Tsui. Department of Urology,
Chang Gung Memorial Hospital, Taoyuan, Taiwan
Purpose: The aim of this study was to compare the early clinical outcomes
between diabetic patients and non-diabetic patients receiving robotic
assisted radical prostatectomy for prostate cancer.
Materials and Methods: Records were obtained from a review of database
for prostate cancer patients receiving robotic assisted radical prostatec-
tomy of Chang-Gung Memorial Hospital, Taiwan, from January 2012 to
December 2014. The patients underwent a detailed physical examination
and medical history review and were divided into two groups: diabetic
group and non-diabetic group. The preoperative variables, intraoperativeand postoperative data were compared among the two groups. Their
biochemical recurrence free survival and the urinary continence recovery
were also taken into comparison.
Results: A total of 363 patients (84 DM; 279 non-DM) were enrolled in our
study. Our data revealed that the patients of DM cohort were older in age
(68 vs. 65 year old, p¼ 0.002) and higher in BMI (26.2 vs. 24.8 kg,
p¼ 0.009). The DM cohort also had a higher percentage of clinical T3a
(35.7% vs. 26.5%, p< 0.001) and Gleason score 8e10 (26.2% vs.14.3%,
p¼ 0.019). Intraoperatively, the two groups were similar in regard to
operative time, blood loss, hospital stay, transfusion rates, and surgical
complication rates. However, the ﬁnal pathology stage of the DM cohort
seemed to be more advanced than that of the non-DM cohort. Although
their biochemical recurrence free survivals were similar, the speeds of
recovery from urinary incontinence were quite different. The continence
rate of DM group over post-OP 3 months, 6 months, and 12 months were
30.9%, 45.0%, and 62.8%, respectively, while the non-DM group were 43.0%,
66.5%, and 94.9%, respectively (p< 0.001).
Conclusion: Among the prostate cancer patients receiving robotic assisted
radical prostatectomy, the DM group had a more advanced T stage
compared to the non-DM group. Their urinary continence also recovered
more slowly.
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THE SAFETY OF EN-BLOC-RESECTION OF RENAL PEDICLE DURING
LAPAROSCOPIC NEPHRECOTMY AND NEPHROURETERECTOMY
Kuan-Chun Huang 1, Allen Wen-Hsiang Chiu 2,3, Wun-Rong Lin 1, Marcelo
Chen 2,4, Stone Yang 1, Yung-Chiong Chow1,2, Wei-Kung Tsai 1, Pai-Kai
Chiang 1, Huang-Kuang Chang 1, Wen-Chou Lin 1, Jong-Ming Hsu 1,2, Ting-
Po Lin 1, Chih-Chiao Lee 1. 1Department of Urology, Mackay Memorial
Hospital, Taipei, Taiwan; 2Mackay Medical College, New Taipei City,
Taiwan; 3 School of Medicine, National Yang-Ming University, Taiwan;
4Mackay Junior College of Medicine, Nursing, and Management, New
Taipei City, Taiwan
Purpose: As a previous perception, renal hilum en bloc ligation may in-
crease the risk of renal arteriovenous ﬁstula (AVF). We evaluated the safety
and effectiveness of en bloc ligation of renal pedicale using endo-gastro-
intestinal anastomosis stapler (endo-GIA) during laparoscopic neph-
recotmy and nephroureterectomy.
Materials and Methods: Medical records were reviewed of 243 patients
underwent laparoscopic nephrecotmy and nephroureterectomy from
January, 2002 to May, 2015. Preoperative evaluation include estimate
blood loss (EBL), operative time (OP time), the method to ligate renal
pedicle (en bloc versus separate) are documented. Comparison of EBL and
op time are only performed among patients received laparoscopic ne-
phrectomy. Postoperative evaluation include newly diagnosis of heart
failure and we also use the CT (computerized tomography) scan for eval-
uating the possibility of formation of AVF.
Results: Average age of our patients was 65.42 years (range 12 to 89 yrs)
including nephrectomy: 80 patients; nephroureterectomy: 143 patients;
nephroureterectomy plus cystectomy: 19 patients. 103 patients have
adequate out patient clinic medical records for evaluation and the mean
follow-up is 5.3 months (1938.7 days, 15e6033 days). 70 patients have
accurate record for the method of renal hilum ligation. (Group A: en bloc,
n¼ 58; Group B: separate, n¼ 12) Among these two groups, there are no
signiﬁcant deference in EBL (p¼ 0.343) and OP time (p¼ 0.635). In our
follow up, only 4 patients have newly diagnosis of heart failure. One of
them eventually loss follow-up. The rest of 3 patients have no evidence of
AVF formation under image and physical examination.
Conclusion:Enbloc ligationof renalpedicleduring laparoscopicnephrecotmy
and nephroureterectomy using endo-GIA is safe with no evidence of AVF for-
mationwith average follow up for 5.3 months (longest follow-up for 20 years)
PD12-6:
SHOULD WE SHIFT TO RETZIUS-PRESERVING ROBOTIC ASSISTED
LAPAROSCOPIC RADICAL PROSTATECTOMY?
Chia-yen Lin, Yen-chuan Ou, Cheng-kuang Yang. Division of Urology,
Department of Surgery, Taichung Veterans General Hospital, Taiwan
Abstracts / Urological Science 27 (2016) S1eS23S22Purpose: Some studies reported a comparable oncological outcome and
better early continence rate of Retzius-preserving robotic assisted lapa-
roscopic radical prostatectomy (RALP). We want to compare the early
perioperative and continence outcome. And we are also eager to know if
the learning curve of Retzius-preserving surgery would compromise the
outcome or not?
Materials and Methods: We selected patient with organ-conﬁned
prostate cancer ( cT2c), PSA  40, Gleason score of biopsy  8, prostate
volume  50 ml and BMI < 35. We design a case control matching study
with 20 cases of each Retzius-preserving RALP and conventional RALP
group. Postoperative parameter and early continence result was
compared.
Results: From Febuary, 2015 to Febuary, 2016, total 84 cases of RALP were
performed in VGHTC. Twenty of them underwent Retzius-preserving
RALP. There is no statistical difference of preoperative characteristics.
There were no signiﬁcant differences in estimated blood loss, mean length
of hospital stay, intra- and postoperative complication rates, pathological
stage of disease, Gleason scores, tumour volumes and positive surgical
margins between the conventional RALP and Retzius-sparing RALP groups.
However, console time, Vesicourethral anastomosis time were longer for
Retzius-sparing RALP. There is no signiﬁcant difference of early continence
at 4 weeks between two groups.
Conclusion: Based on the early result of this study, Retzius-preserving
RALP is a feasible and safe treatment choice for localized prostate cancer.
Both console time and anastomosis time are favoring to conventional RALP.
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SPOCK1 EXPRESSION PREDICTS PROGNOSIS IN PROSTATE CANCER
Shao-Chuan Wang 1,2, Wen-Wei Sung 3,4,5,6, Chih-Jung Chen 3,4,6, Horng-
Rong Chang 1,7. 1 Institute of Medicine, Chung Shan Medical University,
Taichung, Taiwan; 2Department of Urology, Chung Shan University
Hospital, Taichung, Taiwan; 3Department of Surgical Pathology, Changhua
Christian Hospital, Changhua, Taiwan; 4 School of Medicine, Chung Shan
Medical University, Taichung, Taiwan; 5Department of Medical Education,
Chung Shan Medical University Hospital, Taichung, Taiwan; 6Department
of Medical Technology, Jen-Teh Junior College of Medicine, Nursing and
Management, Miaoli, Taiwan; 7Department of Nephrology, Chung Shan
Medical University Hospital, Taichung, Taiwan
Purpose: Prostate cancer is a common cancer and it can often be treated
successfully. The 15-year survival rate is more than 90% in patients with
early stage, However, once the tumor metastasis occurred, the prognosis
got signiﬁcantly worse. Therefore, to identify patients with malignant
potential while diagnosing might improve clinical outcome. The aim of
this study was to evaluate the expression of SPOCK1 (sparc/osteonectin,
cwcv and kazal-like domains proteoglycan (testican) 1) and its clinical
signiﬁcance in prostate cancer.
Materials and Methods: SPOCK1 expression was measured by immuno-
histochemical staining of samples from 71 patients with prostate cancer.
The correlation between SPOCK1 expression and clinicopathological fea-
tures was quantitatively analyzed. The prognostic value of SPOCK1 for
overall survival was determined by Kaplan-Meier analysis and Cox pro-
portional hazard models. For underlying molecular mechanism, prostate
cancer cell lines were used and SPOCK1 expression was knock-down via
siRNA. Migration and invasion assay were performed to determined the
tumor malignancy. The downstream signaling pathway will be analyzed
with real-time RT-PCR and western blot.
Results: Seventy-one patients with mean age of 74.4 years (range 59 to 97
years) were included. Clinicopathological features, including histological
type, differentiation, lymph node metastasis, TNM stage, and tumor size
were assessed. Patients with high SPOCK1 expression were more prone to
be advanced stage. As to the prognosis, the median follow-up for overall
survival was 5.2± 2.9 years (range: 0.7 to 11.8 years). Moreover, a high
POCK1 expression level was correlated with poor survival. The underlying
mechanism is under investigation.
Conclusion: Our results suggest that SPOCK1 expression is enhanced in
prostate cancer. High SPOCK1 expression, either alone or in combinationwith other pathologic staging factors, may therefore serve as a poor
prognostic marker for prostate cancer.
PD13-2:
PATIENT-SPECIFIC VERSUS NON-PATIENT-SPECIFIC ALERTS IN
DECISION SUPPORT SYSTEM TO PREVENT CONTRAST-INDUCED
NEPHROPATHY: A RANDOMIZED CONTROLLED TRIAL
Chung-You Tsai 1,2, Shi-Heng Wang 3, Yu-Chuan Li 4. 1Division of Urology,
Department of Surgery, Far Eastern Memorial Hospital, Taiwan; 2 Institute
of Biomedical Informatics, National Yang-Ming University, Taiwan;
3 Institute of Epidemiology and Preventive Medicine, College of Public
Health, National Taiwan University, Taiwan; 4College of Medicine Science
and Technology (CoMST), Taipei Medical University, Taiwan
Purpose: Physicians ordering contrast imaging should identify patient
risks and prevent contrast-induced nephropathy (CIN). Our aim is to
determine whether patient-speciﬁc or non-patient-speciﬁc alerts in clin-
ical decision support system triggers higher compliance with guidelines to
prevent CIN.
Materials and Methods: A 3-arm cluster randomized controlled trial was
conducted in two university hospitals using the same computerized
physician order entry. Eligible physicians were randomized to receive
patient-speciﬁc alerts, non-patient-speciﬁc alerts or no intervention
(groups 1e3 respectively). Patient-speciﬁc alerts automatically prompted
only when CIN risk was encountered and provides patient-speciﬁc data to
physicians, while non-patient-speciﬁc alerts always prompted regardless
of risk without providing patient-speciﬁc data. CIN risk was stratiﬁed as
high-risk, low-risk and minimal-risk according to patient's renal function.
Contrast imaging order-cancellation rate was measured as primary
outcome.
Results: Orders for 5372 patients from 99 physicians were analyzed. Renal
function and risk distributions of patients were not statistically different
among groups. Order-cancellation rates were 32.1%, 14.3%, 1.7% for high
risk patients, and 7.2%, 3.0%, 1.3% for low risk patients in groups 1e3,
respectively. Using generalized linear model, signiﬁcant order-cancellation
factors in at-risk patients were non-patient-speciﬁc alert (p¼ 0.04), pa-
tient-speciﬁc alert (p< 0.0001), high CIN risk (p¼ 0.003), and physicians
with low contrast imaging ordering volume (p< 0.0001). Order-cancella-
tion effects were compared and measured by odds ratio (OR). For high risk
patients, patient-speciﬁc versus non-patient-speciﬁc alerts OR was sig-
niﬁcant at 2.73 (95%CI 1.09e6.84), while patient-speciﬁc vs. control
OR¼ 28.32 (95%CI 3.21e249.65), and non-patient-speciﬁc vs. control
OR¼ 9.17 (95%CI 0.96e87.55).
Conclusion: Patient-speciﬁc alert signiﬁcantly outperformed non-patient-
speciﬁc alert in physician compliance with guidelines.
PD13-3:
CLINICAL OUTCOME OF AUGMENTATION ENTEROCYSTOPLASTY FOR
PATIENTS WITH KETAMINE-INDUCED CYSTITIS
Yu Khun Lee, Hann-Chorng Kuo. Department of Urology, Hualien Tzu Chi
Hospital, Huelien, Taiwan
Purpose: To analyze the clinical outcome of patients with KC managed
with augmentation enterocystoplasty (AE).
Materials and Methods: We retrospectively collected and analyzed the
medical records and video-urodynamic (VUD) test results of 26 patients
who underwent AE as treatment for refractory KC during the period
2009e2014. Data from VUD studies performed before AE and 3e6 months
after surgery that were analyzed in this study included cystometric
bladder capacity (CBC), post-void residual (PVR) urine volume, maximum
urinary ﬂow rate (Qmax), voided volume and bladder compliance. A self-
report questionnaire was used to assess patient satisfaction with AE.
Results: Patients included 14women and 12men aged 20e43 years (mean
age, 28.5 years) with an average duration of ketamine abuse of 4.7 years
(range, 1e7 years). All patients had contracted bladder, 9 had hydro-
nephrosis and 10 had vesicoureteral reﬂux (VUR). There was signiﬁcant
improvement in CBC (52.7± 29.7 v 327± 69.4 mL, P< 0.0001), Qmax
(6.94± 4.32 v 13.7± 4.96 mL/s, P< 0.0001), PVR (8.08± 19.2 v
82.6± 91.5 mL, P< 0.0001), voided volume (44.1± 28.3 v 250.7 ± 133.4 mL,
